changes in tumour biomarkers after neoadjuvant chemotherapy in breast cancer
Published 8 years ago • 931 plays • Length 2:13Download video MP4
Download video MP3
Similar videos
-
2:09
tumour biomarker changes after neoadjuvant chemotherapy in breast cancer
-
4:38
exciting updates in biomarkers of response to neoadjuvant chemotherapy
-
3:01
alternate: neoadjuvant chemotherapy in er her2- breast cancer
-
1:29
biomarker identification in nsclc treated with neoadjuvant chemo-io
-
0:29
the role of immune biomarkers in guiding breast cancer treatment decisions
-
2:39
the role of biomarkers in guiding treatment for early-stage breast cancer
-
1:10
dr. tereffe on treatment after neoadjuvant chemotherapy in breast cancer
-
6:08
prognostic biomarkers in breast cancer – the latest developments
-
6:09
ki-67 index after neoadjuvant et as a prognostic biomarker for hr /her2- early breast cancer
-
1:59
effectiveness of icis in the neoadjuvant and post-neoadjuvant breast cancer setting
-
27:03
triple negative breast cancer: predictive and prognostic biomarkers for neo/adjuvant therapy
-
36:42
evaluation of breast specimens after neoadjuvant chemotherapy
-
1:29
the predictive value of treatment response after neoadjuvant therapy
-
0:26
identifying the need for neoadjuvant chemotherapy in stage i breast cancer
-
1:24
detection of ctdna post neoadjuvant chemo is associated with disease relapse in early breast cancer
-
38:22
adjuvant/neoadjuvant therapy for breast cancer: updates and molecular predictors of benefit
-
1:02:45
biomarkers in breast cancer: current practice, opportunities and unmet needs
-
14:51
breast cancer neoadjuvant chemotherapy: for patients
-
1:45
dr. king on neoadjuvant chemotherapy in breast cancer